Benzinga | Dec 8, 2020 07:24AM EST

JMP Securities Initiates Coverage On Mirati Therapeutics with Market Perform Rating

JMP Securities analyst Silvan Tuerkcan initiates coverage on Mirati Therapeutics (NASDAQ:MRTX) with a Market Perform rating.